IOF International Orthodontics Foundation - Committees

The IOF Science Committee assumes a crucial role in overseeing the IOF Research Grants Program. Their wealth of expertise and knowledge in the field of orthodontics empowers them to provide valuable suggestions and insights, ensuring the Research Grants Program is structured to support groundbreaking research initiatives.

Throughout the grant application process, the committee meticulously reviews each eligible submission, evaluating the research proposals based on their scientific merit, potential impact, and alignment with the program's objectives.

Dr. Kang Ting
DMD., DMEDSC

Adjunct Faculty, The ADA Forsyth Institute, Cambridge, USA
Executive Director of IOF
Co-chair of IOF Science Committee

Dr. Kang Ting currently is an adjunct faculty at the ADA Forsyth Institute, Cambridge, MA, USA.

Dr. Eric Kang Ting graduated from Harvard school of Dental Medicine with high honor and the gold award with DMD in 1991 and PhD, and an orthodontic certificate from Harvard in 1994. He currently is an adjunct faculty at the ADA Forsyth Institute, Cambridge, MA, USA. He was formerly the Academic Senate Tenured Professor since 2002 and founding chair in the Division of Growth and Development at UCLA. The Division comprises the Sections of Orthodontics and Pediatric Dentistry. Besides his teaching and clinical responsibilities in Orthodontics. Dr. Ting has google scholar h-index of 62 – as one of the top three highest orthodontists globally. Ting’s original research has received well over 12,000 citations. It has been published in many leading journals, including Nature Communications, Journal of Clinical Investigation, PLOS One, and Biomaterials, etc as the principal author. Dr. Ting has been served as a PARC AAOF committee member since 2015. In 2018, Professor Ting and his team received the International Space Station (ISS) Innovation Award for Biology and Medicine for Development of NELL-1 Bone-Growth Systemic Therapy by the American Astronautical Society. Dr. Ting has received over US 30M in funding from the US government as a key investigator in his career. Stemmed from his research, two novel biologic drugs are currently in FDA clinical trials for scar reduction, and bone regeneration respectively.

The Founding Committee defines the strategy of IOF. According to the strategy, the committee sets the short-term and long-term objectives for developing different programs and initiatives.

Furthermore, the committee is responsible for allocating funds to the Science Committee and providing senior counsel on medical affairs. Oversight is provided by an independent board, which is also responsible for electing the IOF chairperson and executive directors.

Dr. Kang Ting
DMD., DMEDSC

Adjunct Faculty, The ADA Forsyth Institute, Cambridge, USA
Executive Director of IOF
Co-chair of IOF Science Committee

Dr. Kang Ting currently is an adjunct faculty at the ADA Forsyth Institute, Cambridge, MA, USA.

Dr. Eric Kang Ting graduated from Harvard school of Dental Medicine with high honor and the gold award with DMD in 1991 and PhD, and an orthodontic certificate from Harvard in 1994. He currently is an adjunct faculty at the ADA Forsyth Institute, Cambridge, MA, USA. He was formerly the Academic Senate Tenured Professor since 2002 and founding chair in the Division of Growth and Development at UCLA. The Division comprises the Sections of Orthodontics and Pediatric Dentistry. Besides his teaching and clinical responsibilities in Orthodontics. Dr. Ting has google scholar h-index of 62 – as one of the top three highest orthodontists globally. Ting’s original research has received well over 12,000 citations. It has been published in many leading journals, including Nature Communications, Journal of Clinical Investigation, PLOS One, and Biomaterials, etc as the principal author. Dr. Ting has been served as a PARC AAOF committee member since 2015. In 2018, Professor Ting and his team received the International Space Station (ISS) Innovation Award for Biology and Medicine for Development of NELL-1 Bone-Growth Systemic Therapy by the American Astronautical Society. Dr. Ting has received over US 30M in funding from the US government as a key investigator in his career. Stemmed from his research, two novel biologic drugs are currently in FDA clinical trials for scar reduction, and bone regeneration respectively.

The International Orthodontics Foundation (OF) is a not-for-profitorganization co-founded by CareCapital Group and more than 10 leading expertsfrom around the world. As a platform for international collaborative innovation, IOFis dedicated to advancing orthodontic care globally by exploring and promotinginnovative treatment ideas and technologies.

IOF Organization

IOF Board

Define IOF’s overarching strategy and establish key objectives for short to medium term.

Allocate financial resources efficiently to align with IOF’s strategic vision.

Elect the Chairperson, committee members, and the IOF Executive Board members.

IOF Executive Board

Oversee day-to-day operations, providing strategic advice to the Foundation Board.

Ensure open communication with all committees, maintaining dialogue for informed decision-making.

Manage the Operation Office, review regular IOF reports, and enforce governance that aligns with the Foundation's goals.

IOF Science Committee

The IOF Science Committee is integral to advancing the foundation's mission of fostering research and innovation within the field of orthodontics. The committee's specific

responsibilities include:

Overseeing the IOF grants process from announcement to award, ensuring a transparent, equitable, and merit-based system.

Evaluating all applications for IOF Grants and Scholarships with rigor and upholding the highest standards of academic excellence.

Advising on the strategic direction for research initiatives, identifying emerging trends, and setting priorities that align with IOF's long-term objectives.

Facilitating collaborations and partnerships with academic institutions, industry, and other stakeholders to advance orthodontic research.